GWN Securities Inc. Takes Position in Medpace Holdings, Inc. (NASDAQ:MEDP)

GWN Securities Inc. bought a new position in shares of Medpace Holdings, Inc. (NASDAQ:MEDP - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 809 shares of the company's stock, valued at approximately $278,000.

Several other hedge funds and other institutional investors have also bought and sold shares of MEDP. R Squared Ltd bought a new position in shares of Medpace during the 4th quarter worth approximately $30,000. SBI Securities Co. Ltd. bought a new position in Medpace during the fourth quarter worth $31,000. Stone House Investment Management LLC acquired a new stake in Medpace in the third quarter worth $33,000. Jones Financial Companies Lllp increased its stake in Medpace by 2,750.0% in the fourth quarter. Jones Financial Companies Lllp now owns 114 shares of the company's stock valued at $38,000 after purchasing an additional 110 shares in the last quarter. Finally, Lindbrook Capital LLC raised its holdings in shares of Medpace by 27.6% during the fourth quarter. Lindbrook Capital LLC now owns 134 shares of the company's stock valued at $45,000 after purchasing an additional 29 shares during the period. Institutional investors and hedge funds own 77.98% of the company's stock.

Analysts Set New Price Targets

Separately, Robert W. Baird raised their target price on Medpace from $354.00 to $362.00 and gave the company a "neutral" rating in a research note on Monday, January 27th. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and an average target price of $381.44.

Remove Ads

Medpace Trading Up 1.4 %

Medpace stock traded up $4.60 during trading on Friday, hitting $324.23. 434,202 shares of the company were exchanged, compared to its average volume of 288,542. The company has a market capitalization of $9.88 billion, a P/E ratio of 25.67, a PEG ratio of 3.81 and a beta of 1.47. The business's 50 day moving average is $338.25 and its 200 day moving average is $340.10. Medpace Holdings, Inc. has a 52 week low of $302.01 and a 52 week high of $459.77.

Medpace (NASDAQ:MEDP - Get Free Report) last announced its earnings results on Monday, February 10th. The company reported $3.67 EPS for the quarter, beating the consensus estimate of $2.96 by $0.71. Medpace had a net margin of 19.17% and a return on equity of 51.48%. Equities analysts expect that Medpace Holdings, Inc. will post 12.29 EPS for the current year.

Medpace Company Profile

Medpace Holdings, Inc engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance.